Grant: Master's Award: Canada Graduate Scholarships
University of Ottawa
$17,500.00
Does the absence of dystrophin during somitogenesis dysregulate myogenic progenitor cell divisions and differentiation in the mdx mouse
FY 2018-19
Summary
Duchenne Muscular Dystrophy (DMD) is a fatal muscle degenerative disease that afflicts 1 in 3500 male children. DMD is caused by a loss-in-function mutation to the protein Dystrophin which normally maintains muscle fibre structure and regulates the division kinetics of muscle stem cells (MuSCs). The result of Dystrophin deficiency is progressive weakening and breakdown of muscle that is thought to manifest at ~3-5 years of age. However, we recently demonstrated that Dystrophin is expressed in adult MuSCs and that Dystrophin deficient 2-week-old mice have an unusually low proportion of asymmetric cell divisions that precede the major regeneration and inflammatory phase thought to trigger DMD. Considering our findings, we hypothesize that dystrophin deficiency in embryogenesis is a major contributor to the disease manifestation. I propose a comparative study between mdx (a model for DMD) and wild type C57BL/10ScSn mouse embryos to elucidate the role of Dystrophin in muscle development and define the homeostatic dysregulation in myogenic progenitor MRF expression. I hypothesize that dystrophic embryos will express abnormal MRF expression, delayed cell migration, and decreased abilities to differentiate. Moreover, I will profile dystrophin deficient myogenic progenitor cells to understand the underlying mechanisms of aberrant muscle development that will highlight novel therapeutic intervention. In conclusion, my project will provide insight into the manifestation of DMD in utero that was not previously investigated and change the landscape of DMD research.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
416189
Name
Esper Marie E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Does the absence of dystrophin during somitogenesis dysregulate myogenic progenitor cell divisions and differentiation in the mdx mouse
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Development; Duchenne'S Muscular Dystrophy; Dystrophin; Mdx Mouse; Muscle; Muscle Stem Cells; Myogenesis; Satellite Cells; Somitogenesis; Stem Cells
Abstract
Duchenne Muscular Dystrophy (DMD) is a fatal muscle degenerative disease that afflicts 1 in 3500 male children. DMD is caused by a loss-in-function mutation to the protein Dystrophin which normally maintains muscle fibre structure and regulates the division kinetics of muscle stem cells (MuSCs). The result of Dystrophin deficiency is progressive weakening and breakdown of muscle that is thought to manifest at ~3-5 years of age. However, we recently demonstrated that Dystrophin is expressed in adult MuSCs and that Dystrophin deficient 2-week-old mice have an unusually low proportion of asymmetric cell divisions that precede the major regeneration and inflammatory phase thought to trigger DMD. Considering our findings, we hypothesize that dystrophin deficiency in embryogenesis is a major contributor to the disease manifestation. I propose a comparative study between mdx (a model for DMD) and wild type C57BL/10ScSn mouse embryos to elucidate the role of Dystrophin in muscle development and define the homeostatic dysregulation in myogenic progenitor MRF expression. I hypothesize that dystrophic embryos will express abnormal MRF expression, delayed cell migration, and decreased abilities to differentiate. Moreover, I will profile dystrophin deficient myogenic progenitor cells to understand the underlying mechanisms of aberrant muscle development that will highlight novel therapeutic intervention. In conclusion, my project will provide insight into the manifestation of DMD in utero that was not previously investigated and change the landscape of DMD research.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Esper, Marie E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~